Effect of surfactant on 5-aminolevulinic acid uptake and PpIX generation in human cholangiocarcinoma cell

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 80, Issue 2, 2012, Pages 453-458

  Chung, Chung Wook ^a   Kim, Cy Hyun ^a   Choi, Kyung Ha ^a   Yoo, Jin Ju ^a   Kim, Do Hyung ^a   Chung, Kyu Don ^b   Jeong, Young Il ^a   Kang, Dae Hwan ^a  

^a Pusan National University Yangsan Hospital   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

5 Aminolevulinic acid; Cholangiocarcinoma; Penetration enhancer; Photodynamic therapy; Pluronic F68; Tween 80

Indexed keywords

AMINOLEVULINIC ACID; POLOXAMER; POLYSORBATE 80; PROTOPORPHYRIN;

BILE DUCT CARCINOMA; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TUMOR LEVEL; FLUORESCENCE; HUMAN; HUMAN CELL; LIGHT INTENSITY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PROTEIN SYNTHESIS; SURVIVAL RATE; TUMOR CELL LINE;

AMINOLEVULINIC ACID; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CELL SURVIVAL; CHOLANGIOCARCINOMA; EXCIPIENTS; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLOXAMER; POLYSORBATES; PROTOPORPHYRINS; SURFACE-ACTIVE AGENTS;

EID: 84856598681     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.10.008     Document Type: Conference Paper

References (32)

1. D.S. Sandhu, and L.R. Roberts Diagnosis and management of cholangiocarcinoma Curr. Gastroenterol. Rep. 48 2008 43 52
2. T.M. Welzel, K.A. McGlynn, A.W. Hsing, T.R. O'Brien, and R.M. Pfeiffer Impact of classification of hilar cholangiocarcinomas (Klastskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States J. Natl. Cancer Inst. 98 2006 873 875 (Pubitemid 43923444)
3. Q. Peng, T. Warloe, K. Berg, J. Moan, M. Kongshaug, K.E. Giercksky, and J.M. Nesland 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges Cancer 79 1997 2282 2308 (Pubitemid 27251011)
4. T. Zoepf, R. Jakobs, A. Rosenbaum, D. Apel, J.C. Arnold, and J.F. Riemann Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer Gasterointest. Endosc. 54 2001 763 766 (Pubitemid 33668686)
5. Q. Peng, K. Berg, J. Moan, M. Kogsshaug, and J. Nesland 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research Photochem. Photobiol. 65 1997 235 251 (Pubitemid 27158805)
6. J. Gaullier, K. Berg, Q. Peng, H. Anholt, P. Selbo, L. Ma, and J. Moan Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture Cancer Res. 57 1997 1481 1486 (Pubitemid 27175564)
7. A. Casas, A. Batlle, A. Butler, D. Robertson, E. Brown, A. MacRobert, and P. Riley Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures Br. J. Cancer 80 1999 1525 1532 (Pubitemid 29308630)
8. C. Perotti, H. Fukuda, G.D. Venosa, A.J. MacRobert, A. Batlle, and A. Casas Porphyrins synthesis form ALA derivatives for photodynamic therapy. In vitro and in vivo studies Br. J. Cancer 90 2004 1660 1665 (Pubitemid 38648253)
9. A.F. Hurlimann, G. Hanggi, and R.G. Panizzon Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion Dermatology 197 1998 248 254 (Pubitemid 28445824)
10. A.C. Williams, and B.W. Barry Penetration enhancers Adv. Drug Deliver. Rev. 56 2004 603 618 (Pubitemid 38326936)
11. Z. Malik, G. Kostenich, L. Roitman, B. Ehrenberg, and A. Orenstein Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice J. Photochem. Photobiol. B - Biol. 28 1995 213 218
12. A. Casas, H. Fukuda, G.D. Venosa, and A. Battle The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolevulinic acid. Implications in cutaneous photodynamic sensitization Br. J. Dermatol. 143 2000 564 572
13. C. Perotti, A. Casas, H. Fukuda, P. Sacca, and A. Batlle Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution Br. J. Cancer 88 2003 432 437 (Pubitemid 36308156)
14. D.I. Morrow, P.A. McCarron, A.D. Woolfson, P. Juzenas, P. Juzenas, A. Juzeniene, V. Iani, J. Moan, and R.F. Donnelly Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches J. Pharm. Pharmacol. 62 6 2010 685 695
15. L. Brancaleon, and H. Moseley Laser and non-laser light sources for photodynamic therapy Lasers Med. Sci. 17 3 2002 173 186
16. C.H. Kim, C.W. Chung, K.H. Choi, J.J. Yoo, D.H. Kim, Y.I. Jeong, and D.H. Kang Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells Int. J. Nanomedicine 6 2011 1357 1363
17. H. Oishi, K. Nomiyama, and K. Tomokuni Fluorometric HPLC determination of d-aminolevulinic acid (ALA) in the plasma and urine of lead workers: biological indicators of lead exposure J. Anal. Toxicol. 20 1996 106 110 (Pubitemid 26085459)
18. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63 (Pubitemid 14203433)
19. J.C. Cendan, R.A. Zlotecki, and J.N. Vauthey Biliary tract cancer Curr. Opin. Gastroenterol. 12 1996 460 465 (Pubitemid 26370612)
20. M.A. Ortner, J. Liebetruth, S. Schreiber, M. Hanft, U. Wruck, V. Fusco, J.M. Müller, H. Hörtnagl, and H. Lochs Photodynamic therapy of nonresectable cholangiocarcinoma Gastroenterology 114 1998 536 542
21. T.J. Dougherty Photodynamic therapy: new approaches Semin. Surg. Oncol. 5 1989 6 16
22. R.F.V. Lopez, N. Lange, R. Guy, and M.V.L.B. Bentley Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters Adv. Drug Deliver. Rev. 56 2004 77 94 (Pubitemid 38045425)
23. J. Webber, D. Kessel, and D. Fromm Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid J. Photochem. Photobiol. B 37 1997 151 153 (Pubitemid 27068149)
24. A. Juzeniene, P. Juzenas, V. Iani, and J. Moan Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model Photochem. Photobiol. 76 3 2002 329 334
25. L. Rodriguez, A. Batlle, C.D. Venosa, S. Battah, P. Dobbin, A.J. MacRobert, and A. Casas Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells Br. J. Pharmacol. 147 2006 825 833
26. S. Battah, S. Balaratnam, A. Casas, S. O'Neill, C. Edwards, A. Batlle, P. Dobbin, and A.J. MacRobert Macromolecular delivery of 5-aminolevulinic acid for photodynamic therapy using dendrimer conjugates Mol. Cancer Ther. 6 3 2007 876 885 (Pubitemid 46554557)
27. L. Bourre, F. Giumtini, I.M. Eggleston, M. Wilson, and A.J. MacRobert 5-Aminolevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy Mol. Cancer Ther. 7 6 2008 1720 1729
28. S. Takatsuka, T. Kitazawa, T. Morita, Y. Horikiri, and H. Yoshino Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant Eur. J. Pharm. Biopharm. 62 2006 52 58 (Pubitemid 41736025)
29. A.V. Kabanov, E.V. Batrakova, and D.W. Miller Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier Adv. Drug Deliver. Rev. 55 2003 151 164 (Pubitemid 36078456)
30. M. Rodriguez, J. Oses, K. Ziani, and J.I. Mate Combined effect of plasticizers and surfactants on the physical properties of starch based edible films Food Res. Int. 39 2006 840 846 (Pubitemid 44163214)
31. J. Hosmer, R. Reed, M.V.L.B. Bentley, A. Nornoo, and L.B. Lopes Microemulsions containing medium-chain glycerides as transdermal delivery systems for hydrophilic and hydrophobic drugs AAPS Pharm. Sci. Tech. 10 2 2009 589 596
32. A. Esteller Physiology of bile secretion World J. Gastroenterol. 14 37 2008 5641 5649